ACBD4 Activators
Acyl-CoA Binding Domain Containing 4 (ACBD4) is a protein encoded by the ACBD4 gene in humans. As the name implies, ACBD4 contains an acyl-CoA binding domain, which allows the protein to bind acyl-CoA esters.Acyl-CoA esters are crucial intermediates in a variety of biochemical reactions, including lipid metabolism and the biosynthesis of other important molecules. By binding to acyl-CoA esters, ACBD4 can influence these processes, regulating the availability and distribution of acyl-CoA within cells.This suggests roles in processes such as fatty acid oxidation, lipid biosynthesis, and the regulation of intracellular lipid pools.
ACBD4, like other proteins with acyl-CoA binding domains, may also play a role in maintaining cellular energy balance and responding to metabolic stress. Changes in the function or expression of ACBD4 could disrupt these processes, leading to metabolic abnormalities.In summary, ACBD4 is a protein that binds to acyl-CoA esters, playing a role in lipid metabolism and maintaining cellular energy balance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fibrates, used to regulate lipid levels, may indirectly affect ACBD4 by influencing lipid metabolism pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
These insulin sensitizers might impact ACBD4 activity through their effects on fatty acid metabolism. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
As a lipid-lowering agent, nicotinic acid might influence ACBD4 activity indirectly by altering lipid profiles. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
These fatty acids, by affecting lipid metabolism, might impact ACBD4 function. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
Similar to monounsaturated fatty acids, polyunsaturated fatty acids may influence ACBD4 activity through lipid metabolic pathways. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Statins, known for lowering cholesterol levels, could indirectly affect ACBD4 function in lipid metabolism. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
Bile acids, involved in lipid digestion and metabolism, might influence ACBD4 activity indirectly. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPAR agonists, regulating lipid metabolism, could impact ACBD4 activity through transcriptional regulation of lipid-related genes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Sirtuin activators, influencing metabolic pathways, may indirectly affect ACBD4 function. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Activators of AMPK, a key regulator of energy balance, might impact pathways relevant to ACBD4 function. | ||||||